BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 23568989)

  • 1. [Immune-mediated neuropathy and anti-glycolipid antibodies].
    Kaida K; Kusunoki S
    Brain Nerve; 2013 Apr; 65(4):413-23. PubMed ID: 23568989
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibodies to gangliosides and ganglioside complexes in Guillain-Barré syndrome and Fisher syndrome: mini-review.
    Kaida K; Kusunoki S
    J Neuroimmunol; 2010 Jun; 223(1-2):5-12. PubMed ID: 20172612
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Antiganglioside antibodies--their pathophysiological effects on Guillain-Barré syndrome and variants].
    Kaida K; Kusunoki S
    Nihon Rinsho Meneki Gakkai Kaishi; 2011; 34(1):29-39. PubMed ID: 21372511
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Antiganglioside complex antibody].
    Hongo Y; Kaida K
    Nihon Rinsho; 2013 May; 71(5):839-44. PubMed ID: 23777091
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibodies against ganglioside complexes in Guillain-Barré syndrome and related disorders.
    Kusunoki S; Kaida K
    J Neurochem; 2011 Mar; 116(5):828-32. PubMed ID: 21214559
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Autoantibodies in Guillain-Barré Syndrome].
    Uchibori A; Chiba A
    Brain Nerve; 2015 Nov; 67(11):1347-57. PubMed ID: 26560950
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibodies to LM1 and LM1-containing ganglioside complexes in Guillain-Barré syndrome and chronic inflammatory demyelinating polyneuropathy.
    Kuwahara M; Suzuki S; Takada K; Kusunoki S
    J Neuroimmunol; 2011 Oct; 239(1-2):87-90. PubMed ID: 21914557
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The immunobiology of Guillain-Barré syndromes.
    Willison HJ
    J Peripher Nerv Syst; 2005 Jun; 10(2):94-112. PubMed ID: 15958123
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Antiganglioside autoantibody profiles in Guillain-Barré syndrome].
    Caudie C; Vial C; Bancel J; Petiot P; Antoine JC; Gonnaud PM
    Ann Biol Clin (Paris); 2002; 60(5):589-97. PubMed ID: 12368145
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-ganglioside antibody-mediated neuronal cytotoxicity and its protection by intravenous immunoglobulin: implications for immune neuropathies.
    Zhang G; Lopez PH; Li CY; Mehta NR; Griffin JW; Schnaar RL; Sheikh KA
    Brain; 2004 May; 127(Pt 5):1085-100. PubMed ID: 14985267
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibodies against gangliosides and ganglioside complexes in Guillain-Barré syndrome: new aspects of research.
    Kusunoki S; Kaida K; Ueda M
    Biochim Biophys Acta; 2008 Mar; 1780(3):441-4. PubMed ID: 17976386
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antiganglioside antibodies and their pathophysiological effects on Guillain-Barré syndrome and related disorders--a review.
    Kaida K; Ariga T; Yu RK
    Glycobiology; 2009 Jul; 19(7):676-92. PubMed ID: 19240270
    [TBL] [Abstract][Full Text] [Related]  

  • 13. GD1b-specific antibody induces ataxia in Guillain-Barre syndrome.
    Kaida K; Kamakura K; Ogawa G; Ueda M; Motoyoshi K; Arita M; Kusunoki S
    Neurology; 2008 Jul; 71(3):196-201. PubMed ID: 18625966
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of humoral immune responses to LM1 ganglioside in guinea pigs.
    Gu Y; Chen ZW; Siegel A; Koshy R; Ramirez C; Raabe TD; Devries GH; Ilyas AA
    J Neuroimmunol; 2012 May; 246(1-2):58-64. PubMed ID: 22464399
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibodies to ganglioside complexes in Guillain-Barré syndrome: clinical correlates, fine specificity and complement activation.
    Notturno F; Luciani M; Caporale CM; Ciarelli A; Uncini A
    Int J Immunopathol Pharmacol; 2009; 22(2):437-45. PubMed ID: 19505396
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Measurement of antiganglioside autoantibodies by immunodot-blot assay: clinical importance in peripheral neuropathies].
    Caudie C; Vial C; Petiot P; Bancel J; Later R; Gonnaud PM
    Ann Biol Clin (Paris); 1999; 57(5):579-88. PubMed ID: 10518060
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Guillain-Barré and Fisher syndromes: update on the pathophysiological role of antiganglioside antibodies].
    Kaida K
    Rinsho Shinkeigaku; 2012; 52(11):914-6. PubMed ID: 23196466
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-ganglioside complex antibodies associated with severe disability in GBS.
    Kaida K; Morita D; Kanzaki M; Kamakura K; Motoyoshi K; Hirakawa M; Kusunoki S
    J Neuroimmunol; 2007 Jan; 182(1-2):212-8. PubMed ID: 17113161
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pathogenicity of anti-ganglioside antibodies in the Guillain-Barré syndrome.
    van Sorge NM; van der Pol WL; Jansen MD; van den Berg LH
    Autoimmun Rev; 2004 Feb; 3(2):61-8. PubMed ID: 15003189
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An anti-ganglioside antibody-secreting hybridoma induces neuropathy in mice.
    Sheikh KA; Zhang G; Gong Y; Schnaar RL; Griffin JW
    Ann Neurol; 2004 Aug; 56(2):228-39. PubMed ID: 15293275
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.